title: In vitro targeted gene electrotransfer to endothelial cells with plasmid DNA containing human endothelin-1 promoter.
abstract: Development of recombinant DNA technologies has allowed us to create new delivery systems that target specific cell types and that can be used in gene therapy. One of these targets is vascular endothelium because of its important role in tumor angiogenesis. For tumor endothelium-specific targeting, we prepared plasmid DNA encoding green fluorescent protein under the control of human endothelin-1 promoter (pENDO-EGFP), which is specific for endothelial cells. First we determined gene electrotransfer parameters for improved transfection of endothelial cells evaluating different osmolarity of electroporation buffer, voltages of applied electric pulses, and addition of fetal bovine serum immediately after electroporation to the cells for improved transfection and survival. Transfection efficacy of pENDO-EGFP in different endothelial and nonendothelial cell lines was determined next. Gene electrotransfer efficacy was evaluated using three different methods: fluorescence microscopy, fluorescence microplate reader, and flow cytometry. Our results showed that transfection efficacy was higher when cells were prepared in hypoosmolar compared to isoosmolar electroporation buffer. Furthermore, immediate addition of fetal bovine serum to the cells after pulsing also improved gene electrotransfer into target cells. We proved expression of EGFP under the control of human endothelin-1 promoter in endothelial cells, which was also significantly higher compared to nonendothelial cells. Taken together, we successfully constructed pENDO-EGFP, which was specifically expressed in endothelial cells using improved gene electrotransfer parameters.
authors: Faculty of Health Sciences, University of Primorska, Polje 42, 6310, Isola, Slovenia.
authors: Natasa
authors: N
authors: Tesic
authors: Maja
authors: M
authors: Cemazar
mesh_terms: D000818:Animals; D001483:Base Sequence; D002021:Buffers; D002460:Cell Line; D002470:Cell Survival; D018274:Electroporation / Q000379:methods; D042783:Endothelial Cells / Q000378:metabolism*; D019332:Endothelin-1 / Q000235:genetics*; D015870:Gene Expression; D023061:Gene Order; D018014:Gene Transfer Techniques; D006801:Humans; D051379:Mice; D008969:Molecular Sequence Data; D010957:Plasmids / Q000235:genetics*; D011401:Promoter Regions, Genetic; D019076:Transgenes
chemical_list: D002021:Buffers; D019332:Endothelin-1
references: Bioelectrochemistry. 2010 Oct;79(2):265-71
references: 20580903
references: J Gene Med. 2010 Jan;12(1):117-25
references: 19941315
references: Gene Ther. 2004 Jan;11(2):224-8
references: 14712307
references: Exp Biol Med (Maywood). 2008 Jul;233(7):840-8
references: 18445769
references: Mol Biotechnol. 2009 Oct;43(2):167-76
references: 19562526
references: J Transl Med. 2004 Jun 25;2(1):22
references: 15219236
references: Br J Cancer. 2003 Jan 27;88(2):163-6
references: 12610497
references: Biol Chem Hoppe Seyler. 1996 Mar;377(3):195-201
references: 8722321
references: Res Commun Chem Pathol Pharmacol. 1991 Dec;74(3):363-9
references: 1775726
references: Curr Pharm Des. 2006;12(29):3817-25
references: 17073680
references: J Vis Exp. 2011 Sep 12;(55):
references: 21931297
references: Biochim Biophys Acta. 2000 Aug 25;1467(2):362-8
references: 11030594
references: FASEB J. 2011 Jan;25(1):16-28
references: 20837776
references: Cancer Gene Ther. 2002 Apr;9(4):399-406
references: 11960291
references: Eur J Vasc Endovasc Surg. 1999 Jan;17(1):9-14
references: 10071611
references: Nat Rev Genet. 2003 May;4(5):346-58
references: 12728277
references: Prostate Cancer. 2012;2012:452795
references: 22666602
references: Curr Gene Ther. 2004 Mar;4(1):89-113
references: 15032617
references: Radiol Oncol. 2011 Sep;45(3):204-8
references: 22933957
references: Gene Ther. 2002 Dec;9(24):1647-52
references: 12457277
references: Toxicol Pathol. 2008 Jan;36(1):97-103
references: 18337227
references: Cancer Res. 1999 Feb 1;59(3):720-7
references: 9973223
references: Science. 1990 Mar 23;247(4949 Pt 1):1465-8
references: 1690918
references: J Cardiovasc Pharmacol. 2001 Jul;38(1):49-57
references: 11444502
references: Mol Reprod Dev. 2008 Jun;75(6):1085-93
references: 18163444
references: PLoS One. 2010 May 12;5(5):e10611
references: 20485554
references: Eur J Biochem. 1989 Jan 15;179(1):109-15
references: 2645133
references: Adv Genet. 2005;54:3-20
references: 16096005
references: J Natl Cancer Inst. 1997 Jan 1;89(1):21-39
references: 8978404
references: J Clin Invest. 1995 Mar;95(3):1335-44
references: 7883980
references: J Membr Biol. 2012 Sep;245(9):583-90
references: 22843161
references: J Virol. 1999 Dec;73(12):9702-9
references: 10559279
references: Biophys J. 1998 Jun;74(6):3015-22
references: 9635756
references: J Biol Chem. 1990 Jun 25;265(18):10446-50
references: 2191950
references: Bioelectrochemistry. 2009 Feb;74(2):265-71
references: 18930698
references: Mol Imaging Biol. 2011 Feb;13(1):43-52
references: 20396957